203 related articles for article (PubMed ID: 36933828)
1. Activated fibroblasts in cardiac and cancer fibrosis: An overview of analogies and new potential therapeutic options.
Nicolini G; Balzan S; Forini F
Life Sci; 2023 May; 321():121575. PubMed ID: 36933828
[TBL] [Abstract][Full Text] [Related]
2. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies.
Liu M; López de Juan Abad B; Cheng K
Adv Drug Deliv Rev; 2021 Jun; 173():504-519. PubMed ID: 33831476
[TBL] [Abstract][Full Text] [Related]
3. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
4. Mechanical stress regulates the mechanotransduction and metabolism of cardiac fibroblasts in fibrotic cardiac diseases.
Tian G; Ren T
Eur J Cell Biol; 2023 Jun; 102(2):151288. PubMed ID: 36696810
[TBL] [Abstract][Full Text] [Related]
5. Diverse origins and activation of fibroblasts in cardiac fibrosis.
Aujla PK; Kassiri Z
Cell Signal; 2021 Feb; 78():109869. PubMed ID: 33278559
[TBL] [Abstract][Full Text] [Related]
6. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
Frangogiannis NG
Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
[TBL] [Abstract][Full Text] [Related]
7. Novel factors that activate and deactivate cardiac fibroblasts: A new perspective for treatment of cardiac fibrosis.
de Oliveira Camargo R; Abual'anaz B; Rattan SG; Filomeno KL; Dixon IMC
Wound Repair Regen; 2021 Jul; 29(4):667-677. PubMed ID: 34076932
[TBL] [Abstract][Full Text] [Related]
8. Cardiac fibrosis.
Frangogiannis NG
Cardiovasc Res; 2021 May; 117(6):1450-1488. PubMed ID: 33135058
[TBL] [Abstract][Full Text] [Related]
9. Advanced
Bracco Gartner TCL; Stein JM; Muylaert DEP; Bouten CVC; Doevendans PA; Khademhosseini A; Suyker WJL; Sluijter JPG; Hjortnaes J
Tissue Eng Part C Methods; 2021 Feb; 27(2):100-114. PubMed ID: 33407000
[TBL] [Abstract][Full Text] [Related]
10. Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis.
Ragazzini S; Scocozza F; Bernava G; Auricchio F; Colombo GI; Barbuto M; Conti M; Pesce M; Garoffolo G
Acta Biomater; 2022 Oct; 152():300-312. PubMed ID: 36055606
[TBL] [Abstract][Full Text] [Related]
11. A New Hypothetical Concept in Metabolic Understanding of Cardiac Fibrosis: Glycolysis Combined with TGF-β and KLF5 Signaling.
Methatham T; Nagai R; Aizawa K
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457114
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional plasticity of fibroblasts in heart disease.
Micheletti R; Alexanian M
Biochem Soc Trans; 2022 Oct; 50(5):1247-1255. PubMed ID: 36281993
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
[TBL] [Abstract][Full Text] [Related]
14. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast mechanosensing, SKI and Hippo signaling and the cardiac fibroblast phenotype: Looking beyond TGF-β.
Landry NM; Dixon IMC
Cell Signal; 2020 Dec; 76():109802. PubMed ID: 33017619
[TBL] [Abstract][Full Text] [Related]
16. Role of Cardiac Fibroblasts in Cardiac Injury and Repair.
Han M; Zhou B
Curr Cardiol Rep; 2022 Mar; 24(3):295-304. PubMed ID: 35028821
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin 6 deficiency transcriptionally up-regulates TGF-β signaling and induces fibrosis in mice.
Maity S; Muhamed J; Sarikhani M; Kumar S; Ahamed F; Spurthi KM; Ravi V; Jain A; Khan D; Arathi BP; Desingu PA; Sundaresan NR
J Biol Chem; 2020 Jan; 295(2):415-434. PubMed ID: 31744885
[TBL] [Abstract][Full Text] [Related]
18. Substrate stiffness modulates cardiac fibroblast activation, senescence, and proinflammatory secretory phenotype.
Felisbino MB; Rubino M; Travers JG; Schuetze KB; Lemieux ME; Anseth KS; Aguado BA; McKinsey TA
Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H61-H73. PubMed ID: 37889253
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21-Dependent Macrophage-to-Fibroblast Signaling Determines the Cardiac Response to Pressure Overload.
Ramanujam D; Schön AP; Beck C; Vaccarello P; Felician G; Dueck A; Esfandyari D; Meister G; Meitinger T; Schulz C; Engelhardt S
Circulation; 2021 Apr; 143(15):1513-1525. PubMed ID: 33550817
[TBL] [Abstract][Full Text] [Related]
20. The Ski-Zeb2-Meox2 pathway provides a novel mechanism for regulation of the cardiac myofibroblast phenotype.
Cunnington RH; Northcott JM; Ghavami S; Filomeno KL; Jahan F; Kavosh MS; Davies JJ; Wigle JT; Dixon IM
J Cell Sci; 2014 Jan; 127(Pt 1):40-9. PubMed ID: 24155330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
